Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Agricultural History|October 28, 2009
Paradox of precision: bright tobacco as technology of transfer, 1880-1937Barbara Hahn
Technology and Culture|June 27, 2017
Must We Embody Context?Barbara Hahn
Polymers|January 9, 2021
Comparing the Influence of Residual Stress on Composite Materials Made of Polyhydroxybutyrate (PHB) and Amorphous Hydrogenated Carbon (a-C:H) Layers: Differences Caused by Single Side and Full Substrate Film Attachment during Plasma CoatingTorben Schlebrowski, Rachida Ouali, Barbara Hahn, et al.
Materials (Basel, Switzerland)|March 4, 2020
Refinement of Sustainable Polybutylene Adipate Terephthalate (PBAT) with Amorphous Hydrogenated Carbon Films (a-C:H) Revealing Film Instabilities Influenced by a Thickness-Dependent Change of sp2/sp3 RatioTorben Schlebrowski, Halima Acharchi, Barbara Hahn, et al.
AIDS (London, England)|April 11, 2006
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activationDouglas Brust, Michael Polis, Richard Davey, et al.
AIDS (London, England)|February 14, 2006
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activationDouglas Brust, Michael Polis, Richard Davey, et al.
Polymers|July 2, 2021
Plasma Supported Deposition of Amorphous Hydrogenated Carbon (a-C:H) on Polyamide 6: Determining Interlayer Completion and Dehydrogenation Effects during Layer GrowthTorben Schlebrowski, Henriette Lüber, Lucas Beucher, et al.
AIDS (London, England)|January 28, 2006
Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patientsChris E Keh, Jean M Shen, Barbara Hahn, et al.
Blood|August 30, 2002
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cellsIrini Sereti, Hector Martinez-Wilson, Julia A Metcalf, et al.
AIDS (London, England)|December 23, 2008
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trialBrian O Porter, Kara B Anthony, Jean Shen, et al.
Pageof 2